Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

By G. W. Hull, F. Rabbani, F. Abbas, T. Wheeler, M. Kattan, P. Scardino. Journal of Urology, 2002

1,015 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. (2004, neutral): “001 cT1a/b 74 (11) 38 (1) 112 (3) cT1c 42 (6) 1,732 (62) 1,774 (51) cT2a 222 (34) 353 (13) 575 (17) cT2b/c 311 (47) 664 (24) 975 (28) cT3 6 (1) 28 (1) 34 (1) No.”
Guidelines on Prostate Cancer (2013, methodology): “For each biopsy site, report the proportion of biopsies positive for carcinoma and the Gleason score, using the system adopted in 2005 (41).”
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004, neutral): “Follow-up after radiotherapy, median (range), mo 45 (1-180)”
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy (2013, background): “About half of these men undergo radical prostatectomy (RP) and nearly 40% will present with one or more clinicopathologic features such as high Gleason score (GS), extra-capsular extension (ECE), positive surgical margins (SM+), seminal vesicle invasion (SVI) or lymph node involvement (N+) that are ”